Tejaswini Deshmukh

2849 Articles
Tejaswini Deshmukh is the contributing editor of RegTech Times, specializing in defense, regulations and technologies. She analyzes military innovations, cybersecurity threats, and geopolitical risks shaping national security. With a Master’s from Pune University, she closely tracks defense policies, sanctions, and enforcement actions. She is also a Certified Sanctions Screening Expert. Her work highlights regulatory challenges in defense technology and global security frameworks. Tejaswini provides sharp insights into emerging threats and compliance in the defense sector.

The George Santos Scandal: A Tale of Fraud, Identity Theft, and Political Corruption

In a case that has shaken the political world, former U.S. Representative George Santos recently pleaded guilty to a range of serious charges, including...

Amsterdam’s Move to Ban Telegram: Addressing Cybersecurity and Espionage Risks

In a significant policy shift, Amsterdam has recently prohibited the use of the Telegram messaging app by its government employees. This decision, effective since...

China’s Postal Services Targeted in Espionage and Biological Sabotage

In a recent disclosure, China's Ministry of State Security (MSS) has unveiled a disturbing trend where postal services are being exploited for espionage and...

Biden Administration’s Controversial Sanctions Waiver Decision on Iran Draws Criticism

In a move that has sparked significant debate, the Biden-Harris administration has recently renewed a sanctions waiver for Iran’s state-controlled broadcaster, the Islamic Republic...

Ex-Blackwater Chief Erik Prince Under FBI Investigation on the Allegations of Arms Sales to Libyan Military Commander

The FBI has initiated an investigation into Erik Prince, the former head of the private military firm Blackwater, over allegations of illegal arms sales,...

Breaking

DMD Advocates Retain the Crown, Win Back-to-Back Titles at LawStrings Pickleball Cup Season 2

 The LawStrings Pickleball Cup: Season 2 successfully concluded in...

Abbott agrees to pay over $384m to settle allegations related to contaminated infant formula — DOJ

Abbott Laboratories (Abbott), an Illinois-based healthcare company that manufactures...